Vivani Medical VANI Proceeds From Issuance Of Common Stock In Connection With Director Private Securities Purchase Agreement Net Of Issuance Costs
Proceeds From Issuance Of Common Stock In Connection With Director Private Securities Purchase Agreement Net Of Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept vani:ProceedsFromIssuanceOfCommonStockInConnectionWithDirectorPrivateSecuritiesPurchaseAgreementNetOfIssuanceCosts.
The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's proceeds from issuance of common stock in connection with director private securities purchase agreement net of issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's proceeds from issuance of common stock in connection with director private securities purchase agreement net of issuance costs?
- Vivani Medical (VANI) reported proceeds from issuance of common stock in connection with director private securities purchase agreement net of issuance costs of $1.24M in Q4 2024.
- What does proceeds from issuance of common stock in connection with director private securities purchase agreement net of issuance costs mean?
- This reflects the net cash proceeds from the issuance of common stock specifically to company directors or insiders via a private securities purchase agreement. It often signals internal confidence in the company's long-term prospects and provides a non-dilutive or strategic capital infusion.